Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00496990 · ClinicalTrials.gov registry record · Phase 2
Treating the Partners of Drug Using Pregnant Women: Stage II
A Phase 2 study of Drug Addiction, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 158
- Enrollment target
- 1
- Study location
NCT00496990: Completed Phase 2 study of Drug Addiction, sponsored by Johns Hopkins University.
NCT00496990 is a Phase 2 study of Drug Addiction that has completed, run by Johns Hopkins University. The registered enrollment target is 158 participants, above the 96-participant average among 13 other Drug Addiction trials with a reported enrollment target (65% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00496990, a Phase 2 study of Drug Addiction, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 158 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a two group randomized design that will compare a novel therapy package (i.e., Research supported treatment intervention, Contingency-based voucher incentives for the male partner's drug abstinence, Specialized MI couples counseling) to standard care for helping drug using partners of drug dependent pregnant women obtain and maintain drug abstinence. Participants will be followed for 22 weeks and have scheduled twice weekly urine sample collection and all participants will have follow-up interviews post-study entry.
Conditions Studied
Interventions
- BEHAVIORAL control
- BEHAVIORAL Enhanced care
Study Locations (1)
Maryland
- Center for Addiction and Pregnancy Johns Hopkins Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2005-10 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
What the finished NCT00496990 record still lists
NCT00496990 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, above the 96-participant average among 13 other Drug Addiction trials with a reported enrollment target (65% higher).
The record links to 1 condition, with Drug Addiction appearing as the primary indexed condition, and to 2 interventions - of which control is the first listed.
NCT00496990 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00496990 about?
NCT00496990 is a clinical study titled "Treating the Partners of Drug Using Pregnant Women: Stage II". This is a two group randomized design that will compare a novel therapy package (i.e., Research supported treatment intervention, Contingency-based voucher incentives for the male partner's drug abstinence, Specialized MI couples counseling) to standard care for helping drug using partners of drug d...
What is the current status of trial NCT00496990?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 158 participants. The study started on 2005-10. Estimated completion is 2010-06.
What conditions does trial NCT00496990 study?
This clinical trial studies the following conditions: Drug Addiction.
What interventions are being tested in trial NCT00496990?
The interventions under investigation include: control (BEHAVIORAL), Enhanced care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00496990?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00496990 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00496990's enrollment target sits among peer trials
158 2nd of 13 higher than 11 of 13 other Drug Addiction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Drug Addiction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Long-Term Treatment of Opioid Use Disorder
RECRUITING · NA
-
Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder
RECRUITING
-
AWAITS: A Web-based E-health Application for Active Illicit Opioid Users
COMPLETED · NA
-
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
COMPLETED
-
Buprenorphine and Integrated HIV Care
COMPLETED · Phase 4
-
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia